Journal article
A pilot study using 99mTc to measure lead and platinum in the human kidney
Abstract
A pilot study has been conducted to investigate the hypothesis that the chemotherapeutic drug, cisplatinum, can mobilize skeletal lead. In vivo measurements of lead and platinum in the kidney of chemotherapy patients were performed with the technique of x-ray fluorescence, using 99mTc in a backscatter geometry. The results of the pilot study were inconclusive; the majority of patients exhibited no evidence of kidney lead at the level of system …
Authors
Todd AC; Chettle DR; Scott MC; Somervaille LJ; Braithwaite RA; Beaney RP; Buxton EJ
Journal
Nuclear Medicine and Biology, Vol. 20, No. 5, pp. 589–595
Publisher
Elsevier
Publication Date
July 1993
DOI
10.1016/0969-8051(93)90027-r
ISSN
0969-8051